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The overall aim of the present study was to explore the relationship between medicinal
use and fatty fish consumption on heart rate variability (HRV) and heart rate (HR) in a
group of forensic inpatients on a variety of medications. A total of 49 forensic inpatients,
randomly assigned to a fish group (n = 27) or a control group (n = 22) were included in
the present study. Before and by the end of the food intervention period HR and HRV
were measured during an experimental test procedure. An additional aim of this paper is
to show how multivariate data analysis can highlight differences and similarities between
the groups, thus being a valuable addition to traditional statistical hypothesis testing. The
results indicate that fish consumption may have a positive effect on both HR and HRV
regardless of medication, but that the influence of medication is strong enough to mask
the true effect of fish consumption. Without correcting for medication, the fish group
and control group become indistinguishable (p = 0.0794, Cohen’s d = 0.60). The effect of
medication is demonstrated by establishing a multivariate regression model that estimates
HR and HRV in a recovery phase based on HR and HRV data recorded during psychological
tests.The model performance is excellent for HR data, but yields poor results for HRV when
employed on participants undergoing the more severe medical treatments. This indicates
that the HRV behavior of this group is very different from that of the participants on no
or lower level of medication. When focusing on the participants on a constant medication
regime, a substantial improvement in HRV and HR for the fish group compared to the
control group is indicated by a principal component analysis and t -tests (p = 0.00029,
Cohen’s d = 2.72). In a group of psychiatric inpatients characterized by severe mental
health problems consuming different kinds of medication, the fish diet improved HR and
HRV, indices of both emotional regulation and physical health.
Keywords: heart rate, heart rate variability, fatty fish, medicine, multivariate data analysis
INTRODUCTION
Psychiatric inpatients are often on a variety of medications, and it
is known that the life expectancy for this group is lower than the
expectancy for the general population (Nome and Holsten, 2012).
Studies have also shown that people suffering from psychiatric
disorders often have deficiencies in key nutrients such as omega-3
fatty acids and vitamin D (Partonen, 1998; Perica and Delas, 2011).
Diet has shown to have a profound effect on both physical health,
e.g., cardiovascular diseases (CVDs; Van Horn et al., 2008), and
the mental health (Timonen et al., 2004). Self-reporting survey
studies and nutrient supplement studies dominate this research
field, due to the difficulties in conducting a well-controlled diet
intervention study. Because of the low life expectancy in psychi-
atric inpatients on a variety of medications more knowledge about
effective health care interventions is needed. Due to the fact that
fatty fish is an important source of essential fatty acids and vita-
min D, nutrients important for both physical and mental health
(Lansdowne and Provost, 1998; Christensen et al., 2001a,b; Ross
et al., 2007; Dobnig et al., 2008; Giovannucci et al., 2008), results
from controlled fish intervention studies may have important
implications.
Although many studies report on the effects a steady diet of
fatty fish may have on the physical and mental health, the number
of studies examining the underlying mechanisms are much rarer.
Heart rate variability (HRV), which is an objective and impor-
tant index of both physical and mental health (Thayer and Lane,
2007), has been mentioned as one such mechanism. HRV is a
measure of beat-to-beat changes in the heart rate (HR), and is a
measure of the interplay of the sympathetic and parasympathetic
branches of the autonomic nervous system. In itself HRV is a
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predictor of sudden death in patients with coronary heart disease
(Kleiger et al., 2005), which makes the relationship between fatty
fish consumption and HRV interesting to investigate. A reduction
in HRV is regarded as an indicator of future fatal or near-fatal
cardiac arrhythmia (Huikuri et al., 2009), and it is thus an impor-
tant measure of an individual’s physical health. Thayer and Lane
developed a model of neurovisceral integration (Thayer and Lane,
2000, 2007, 2009) that connects prefrontal cortex activity with
that of the heart. This theory provides a physiological explana-
tion as to why HRV not only predicts physical, but also emotion-
and self-regulation. Several later studies (Hansen et al., 2003, 2004,
2009) have underpinned the model by associating HRV with exec-
utive functions, the underlying mechanism involved in emotion-
and self-regulation (Shimamura, 2000; Thayer and Lane, 2000).
Mozaffarian et al. (2008) found that changes in various HRV
parameters were related to increased fatty fish intake. This was
done by controlling for factors such as age, gender, ethnic back-
ground, education, smoking, alcohol intake, body mass index,
diabetes mellitus, prevalent coronary heart disease, β-blocker use,
physical activity, and intakes of beef, pork, fried fish and total
calories. However, it is not well established whether the effect of
fish consumption on HRV is direct or indirect (Mozaffarian et al.,
2008). It has been speculated whether serotonin may be involved
in the effect (Hansen et al., 2010) due to the fact that both vitamin
D and omega-3, which are found in fatty fish, are important for
the regulation of serotonin and serotonin is further important for
the regulation of HRV (Stumpf and Privette, 1989; Hibbeln et al.,
2006).
The use of HRV as an indicator of mental and physical health
status is not problem free. A recent paper by Quintana and
Heathers (Quintana and Heathers, 2014) highlights the impact
of respiration on HRV. Several external factors, such as stress,
age, physical shape and sickness affect the HRV, and may thus
disturb the results. CVD may of course disturb the beat pattern
of the heart, and persons suffering from depression tend to have
lower HRV than the normal population (Kemp et al., 2010). There
is a strong link between depression and CVDs, as a substantial
number of CVD patients suffer from depression (Carney et al.,
1987; Gonzalez et al., 1996), and persons diagnosed with depres-
sion run a higher risk of certain CVDs (Anda et al., 1993; Barefoot
et al., 1996; Pratt et al., 1996; Penninx et al., 2001). Another major
influence on HRV is medication. Blood pressure medications
(Bonaduce et al., 1997; Pinar et al., 1998), cholesterol medica-
tion (Riahi et al., 2002; Welzig et al., 2003; Gomes et al., 2010),
β (Cook et al., 1991; Mølgaard et al., 1993; Niemelä et al., 1994;
Sandrone et al., 1994; Ebbehøj et al., 2002) - and α- blockers and
ACE inhibitors (Guedon-Moreau et al., 1997; Shehab et al., 2008)
are all examples of heart medications with either known or sus-
pected effects on HR and HRV. Among antidepressants, the most
commonly used are selective serotonin reuptake inhibitors (SSRI).
Serotonin itself plays a role in the HRV regulation, and an effect of
SSRI on HRV can be expected. Still, various studies come to differ-
ent conclusions as to whether SSRI influences HRV. In their recent
review and meta-analysis, Kemp et al. (2010), concluded that some
antidepressants, although successful in easing the symptoms of
depression, did not improve HRV significantly. As patients with
depression have a higher risk for developing CVD, a treatment that
remedies the psychological symptoms, but leaves the physiological
ones untreated, may imply a lower longevity for this group. Some
studies (Balogh et al., 1993; Khaykin et al., 1998) demonstrate a
positive effect, whereas others (Licht et al., 2010) show a negative
effect on HRV. For other types of antidepressants the situation is
similar, and no consensus seems to have been arrived at (van Zyl
et al., 2008) on their possible effect on HRV.
Recently it was demonstrated that fatty fish consumption
improved sleep quality and resting HRV (Hansen et al., 2014a).
However, in that study only the effect of high frequency (HF) HRV
was investigated and other HRV parameters such as low frequency
(LF) and the LF/HF ratio were not investigated. Thus, a combined
effect of different HRV parameters was not investigated. More-
over, no attempts were made to investigate the effect of various
medications used by the participants on their psychophysiolog-
ical reactivity to different conditions, such as an experimental
mild-stress procedure consisting of a baseline period (resting),
a variety of different cognitive tasks taxing executive function-
ing and a recovery (resting) period. Executive functioning tasks
require focused attention over prolonged periods of time in order
to be performed accurately. Carrying out these tasks can be a
stressful experience. Both increased HR and decreased HRV have
been found during the performance of such tasks (Porges and
Raskin, 1969). Since HRV is associated with mortality, and psychi-
atric inpatients on a variety of medications are known to have a
lower life expectancy than the general population (Nome and Hol-
sten, 2012), investigation of HRV reactivity to different conditions
while controlling for medication may yield important information
of general daily autonomic activity patterns.
A major aim of this study was to generate hypotheses concern-
ing the effects of a fatty fish diet on the HRV and HR reactivity
in a group of psychiatric patients characterized by severe mental
health problems consuming many different kinds of medications.
Here, we focus on heart medication and anti-depressants admin-
istered on a regular basis. In order to generate new hypotheses
the investigation is carried out in an exploratory way using mul-
tivariate data analysis (Principal Component Analysis and Partial
Least Squares), with focus on easily interpretable plots. This tech-
nique represents a valuable addition to the battery of statistical
tests normally carried out. Because of the different findings in the
literature, it was also investigated whether any effect on HRV and
HR could be detected prior to intervention and assigned to the
usage of anti-depressants. Finally, it was investigated whether the
data indicated that users of such medication experienced a differ-
ent effect of the fatty fish intake compared to the participants who
did not use such medication.
MATERIALS AND METHODS
PARTICIPANTS
The present study was part of a larger research project concerning
the effects of fatty fish consumption (Hansen et al., 2014a), where
95 male forensic inpatients characterized by severe emotional
disturbances (e.g., antisocial personality disorders, borderline per-
sonality disorders, generalized anxiety and major depression) had
been randomly assigned into a Fish group and a Control group. In
the current study a subset of 49 participants were suitable for an
investigation of whether the intake of medications had an impact
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on the effect of the fish consumption. Details about the study
progress are reported in Hansen et al. (2014a). The number of
subjects in the fish group was 27. The number of subjects in the
control group was 22. During the test period five subjects with-
drew from the fish group, and six from the control group. Details
on then randomization procedure can be found in Hansen et al.
(2014b).
APPARATUS
Physiological activity was measured by recording HR and HRV
using the Actiheart System (Cambridge Neurotechnology Ltd;
Brage et al., 2005), a compact lightweight device that records HR
and variability of R-R inter-beat intervals. The Actiheart clips onto
a single ECG electrode (M-00-S/50 Blue Sensor) with a short ECG
lead to another electrode that detects the ECG signal. The Actiheart
was placed on the upper chest.
The Actiheart provides interbeat intervals with a resolution of
1 ms, which are used to calculate HR and HRV. HR was defined
as the average HR in beats per minute for an analysis epoch of
1 min. In the frequency domain, HRV was measured as absolute
high frequency power (HF; 0.15–0.4 Hz), absolute low frequency
power (LF; 0.04–0.15 Hz) and their ratio (LF/HF). HF and LF were
derived by fast Fourier transform of the spectrum. The HF com-
ponent is known to reflect primarily parasympathetic influences.
However, concerning the LF there is some controversy. It has been
argued that LF reflects both sympathetic and parasympathetic
activity; others argue that LF reflects only sympathetic activity
(Malliani et al., 1991; Appelhans and Luecken, 2006; Xhyheri et al.,
2012). In the time domain, HRV was measured as the root mean
of the squared successive differences (RMSSD) of the inter-beat
interval. The RMSSD reflects parasympathetic activity. The data
was log transformed prior to analysis (Malik and Task Force of the
European Society of Cardiology the North American Society of
Pacing Electrophysiology, 1996). Artifacts were manually cleaned
by visual inspection using the Actiheart program.
PROCEDURE
The study protocol and all experimental procedures were approved
by the Ethics Committee at the facility in Mauston, WI, USA,
and were in compliance with the Helsinki declaration for research
ethics. Participants were recruited by both written and oral infor-
mation about the study. Thus, the patients were invited to
participate in a research project concerning nutrition and men-
tal health. The participants were informed that the purpose of
the study was to investigate if nutrition (fatty fish or an alterna-
tive meal like chicken, pork, or beef) would have any effects on
mental health. They were also informed that they would be ran-
domly assigned into two groups; one group that would eat fatty
fish (portion size 150–300 g) three times a week and one group
that would eat meat (e.g., chicken, pork, beef) meals three times a
week for a period for 6 months (September–February). For infor-
mation about the fish used in the intervention study, see Hansen
et al. (2014a). The participants signed an informed consent form,
and they were informed about their rights to withdraw from the
study at any time for any reason without penalty. Thus, the study
design was fully disclosed to all participants, and all participants
provided informed consent.
Prior to (July) and toward the end (February) of the inter-
vention period the participants went through a test procedure.
Since the present study is part of a larger project concerning fatty
fish consumption (Hansen et al., 2014a) these procedures involved
collections of various kinds of data such as fasting blood sample,
sleep data, self-report questionnaires as well as an experimen-
tal test procedure measuring psychophysiological activity during
exposure to different executive function tasks. In order to obtain
a broad measure of reactivity, psychophysiological activity was
registered for 5 min of baseline (rest condition), during expo-
sure to the different executive function tasks (i.e., Iowa Gambling
Task, Tower of Hanoi, and N-back tasks; 0–3 back), and during
5 min of recovery (rest condition). The length of executive tasks
varies from task to task, and person to person. Thus, the HRV
was registered for a total period of 50–60 min. During these peri-
ods of time, one measurement epoch lasts for 1 min. This means
that there are five measurements for baseline and recovery (five
epochs of 1 min during a 5 min interval), and a varying number
of measurements for the tasks. All participants were exposed to
exactly the same experimental procedure before (pre) and after
(post) the food intervention period. All participants were tested
individually.
MEDICINAL USE
Copies of all medical records, from 1 month prior to 1 month
after intervention, were available for a subset of participants.
The various drugs administered were classified according to the
Anatomic Therapeutic Chemical Classification System, which is
controlled by the World Health Organization. For each partici-
pant, daily dosages of each pharmaceutical used continuously for
at least 1 week prior to the pre-test period were registered. This was
done to avoid inclusion of drugs to which the participants had not
yet properly responded. The same procedure was carried out for
the post-test. For the forthcoming data analysis, only categories
C (cardiovascular drugs) and N06A (anti-depressants) were used
actively in the analysis.
Some participants were excluded from the data analysis. Par-
ticipation in the project was voluntary, and three participants
withdrew for various reasons during the intervention period. Par-
ticipants released from the facility or transferred to a different
facility during the study were included in the analysis of the
pre-test, but are of course not present in the post-data. Partici-
pants with partially missing journals were excluded from further
analysis. For some participants, a substantial amount of miss-
ing data was observed in the HR and HRV data. Participants
with more than 20% missing data were excluded from further
analysis.
THE DATA TABLES
A data matrix was constructed from the pre-test data. It contained
HR and HRV data for 49 participants. For each participant there
were 40 variables recorded. These were the HR and the four HRV
measures (LF, HF, LF/HF, and RMSSD) recorded during the eight
stages of the experiment: baseline, the six psychological tests and
recovery. A similar matrix was created from the post-intervention
test data. To highlight the effect of the intervention on the HR
and HRV, the pre-test data was subtracted from the post-test data,
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thus yielding a matrix reflecting the change in HR and HRV mea-
sures. The resulting table is hereafter referred to as the change
data. The creation of this matrix necessitated a full set of data
from both before and after the intervention, and thus only 38 par-
ticipants are included in this matrix. Five of the 11 participants
lost to follow up belonged to the fish group, and six belonged to
the control group. Data was logarithmically (base 10) transformed
prior to analysis. Due to the variables being measured using differ-
ent units of measurements, autoscaling was carried out whenever
HR and HRV data was used in the same analysis. For analysis
using only HR or HRV data, mean centering of the variables was
carried out.
THE DATA ANALYTICAL TOOL
The data analytical tool used in the investigation here may be
unfamiliar to many readers. Principal Component Analysis (PCA;
Joliffe, 2002) and Partial Least Squares (Manne, 1987) belong to a
group of methods which may be referred to as latent variable tech-
niques. They are methods frequently employed in chemometrics
and related fields. The strength of these methods comes from their
ability to deal with collinear data structures, in which the vari-
ables exhibit correlations. Another advantage of these methods is
the easily interpreted plots that result from such analysis, and a
presentation of this is to be found in the Results section.
While a more detailed mathematical explanation can be found
in, e.g., Manne (1987) and Joliffe (2002), a brief explanation is
given here. Latent variable methods take a set of correlated, mea-
sured variables (like the HR and HRV data in this study) and
create a new, smaller set of orthogonal latent variables. The latent
variables are linear combinations of the measured variables, and
may be constructed using different criteria. In PCA, the latent
variables (called principal components) are constructed using the
maximum variance criterion. This means that the set of prin-
cipal components are the best lower-dimensional approximation
of the data, and that they represent the major sources of vari-
ation in the data. This makes PCA well suited for exploratory
analysis.
Just like any object (participant in our study) has a value for
each measured variable, all objects have a score for each principal
component. Similarly, the contribution of each measured variable
to the latent variable is expressed as the variable’s loading. Bivari-
ate scatter plots of the first two score or loading vectors give the
best two-dimensional presentation of the major correlation struc-
tures in the data, and reveal similarities and differences among
the objects and variables in a data matrix. This soft modeling
approach can be regarded as a hypothesis generator, since it visu-
alizes relationships in the data that may otherwise go unnoticed.
Latent variables can also be used to confirm or verify precon-
ceived assumptions and hypotheses, since it is possible to carry
out statistical tests on the latent variables. In the present work, the
emphasis has been on data exploration, and less on quantification
and hypothesis testing.
For the creation of regression models, other latent variable tech-
niques are preferred. Rather than focusing on the variance in the
predictors (the independent variables), PLS creates latent variables
focusing on the covariance between the predictors and one or sev-
eral response variables (the dependent variables). Because of the
orthogonalization inherent in PLS, this regression technique does
not suffer from the problem of collinear data that, e.g., multiple
linear regression does.
The multivariate analyses were carried out using Sirius 9.0 from
Pattern Recognition Systems AS, Bergen, Norway (www.prs.no).
RESULTS
Table 1 displays summary statistics for the HR and HRV data at
pre- and post-test. For the executive functioning tasks (EF tasks)
the average HRV and HR values for all cognitive tasks (Iowa Gam-
bling Task, Tower of Hanoi, and N-back tasks; 0–3 back) are
reported.
PRE-TEST
Plots of data are often useful conveyors of information. The data
matrix from the pre-test period contains 40 measurements for
each of the 49 participants. A graphical display of the informa-
tion content in such a large data matrix may seem difficult to
obtain. One alternative is to plot each variable separately (thus
creating 40 plots), or to produce all possible combinations of
bivariate plots of one variable against another. This creates 780
plots, which of course is impossible to carry out. Through PCA
a two-dimensional projection capturing most of the variation in
the data can be obtained, resulting in a bivariate plot to be used for
interpretation. For this particular data set, a two component (two
latent variables) PCA model captures nearly 70% of the variance
in the data. A bivariate plot of these two latent variables is shown
in Figure 1, and it is referred to as a score plot. Since the axes in
Figure 1 are latent variables, information from all 40 measured
variables is used to create this plot showing information on all 49
participants. This multivariate nature of the axes makes the plot
an excellent tool for detecting relationships among the individual
participants. In Figure 1, members of the fish group are plotted in
blue, while red has been used for the control group. This informa-
tion has only been used to color code the plots, and is not included
in the data material.
There is no discernable trace of any grouping of the samples; the
future fish and control group members are spread evenly through-
out the plot. This indicates that the randomization strategy has
been successful, as there is no visible group separation prior to
intervention. A t-test on the scores on the first principal compo-
nent shows that there is no significant difference in the mean value
of the score values of the fish group compared to the control group
(p = 0.38, effect size Cohen’s d = 0.25).
By changing the color coding (but not the underlying model)
clustering can be revealed. Figure 2 is the result of changing the
color coding so that patients on anti-depressants are plotted in blue
and those not using anti-depressants in red. The data analyzed and
the resulting model is the same as in Figure 1, only the color coding
has changed. Figure 2 shows that patients using anti-depressants
differ from the other patients by having a lower score on the first
principal component. The findings from the PCA are confirmed
by a t-test on the mean values of the scores on the first principal
component. This results in a clear identification of a difference
between the groups (p = 0.0037, effect size Cohen’s d = 1.01).
While the score plot shows clustering, the corresponding load-
ing plot is necessary to understand why groupings occur. Figure 3
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Table 1 | Mean values (M) and SD for the heart rate (HR), the root
mean square of successive differences (RMSSD), low frequency
power (LF), high frequency power (HF), and the LF/HF ratio for both
groups during pre- and post-test.
Fish group Control group
M SD n M SD n
Pre-test
Baseline HR 72.96 13.15 27 72.81 13.13 22
Baseline RMSSD 1.44 0.28 27 1.45 0.27 22
Baseline LF 3.02 0.40 27 2.90 0.40 22
Baseline HF 2.22 0.59 27 2.29 0.49 22
Baseline LF/HF 0.82 0.33 27 0.64 0.26 22
EF tasks HR 71.48 13.06 27 70.12 11.82 22
EF tasks RMSSD 7.23 0.34 26 7.05 3.87 22
EF tasks LF 2.82 0.59 26 2.86 0.37 22
EF tasks HF 2.14 0.75 26 2.36 0.46 22
EF tasks LF/HF 0.69 0.27 26 0.53 0.22 22
Recovery HR 70.47 12.08 26 69.71 12.14 22
Recovery RMSSD 1.62 0.31 27 1.63 0.27 22
Recovery LF 3.30 0.43 27 3.32 0.39 22
Recovery HF 2.61 0.61 27 2.69 0.46 22
Recovery LF/HF 0.79 0.41 27 0.72 0.28 22
Post-test
Baseline HR 71.08 12.50 22 76.11 9.87 16
Baseline RMSSD 1.56 0.28 22 1.47 0.32 16
Baseline LF 3.11 0.40 22 2.99 0.59 16
Baseline HF 2.39 0.54 22 2.36 0.54 16
Baseline LF/HF 0.78 0.40 22 0.68 0.17 16
EF tasks HR 70.37 11.33 22 73.96 11.08 16
EF tasks RMSSD 1.54 0.36 22 1.52 0.26 16
EF tasks LF 2.92 0.47 22 2.81 0.49 16
EF tasks HF 2.37 0.70 22 2.38 0.49 16
EF tasks LF/HF 0.57 0.30 22 0.47 0.28 16
Recovery HR 69.75 9.98 22 75.17 10.81 16
Recovery RMSSD 1.63 0.30 22 1.49 0.23 16
Recovery LF 3.26 0.38 22 2.97 0.44 16
Recovery HF 2.61 0.62 22 2.44 0.40 16
Recovery LF/HF 0.73 0.33 22 0.60 0.27 16
The HRV data are log-transformed. The number of participants in each group is in
the column n.
shows the loading plot. Again, color coding has been used. HR
variables are plotted in red, and blue has been used for the RMSSD
variables. The HF variables are in black, and green has been used
for LF. The LF/HF ratio is plotted in brown.
Figure 3 shows that participants with a low score on the first
principal component (the patients using anti-depressants) have a
tendency to have a higher HR (red) and LF/HF (brown) compared
to the rest of the patients.
FIGURE 1 | Score plot of the first two principal components of the
pre-test data. Blue color is used for the fish group, and red for the control
group.
FIGURE 2 | Score plot of the first two principal components of the
pre-test data. Blue color is used for participants using anti-depressants,
and red for those without such usage.
The recovery phase is an indicator on how the body adjusts to
the normal situation after a period of mild stress. It was thought to
be of interest to see if the patients on anti-depressants responded
differently during recovery. This was done by creating PLS regres-
sion models that modeled recovery behavior as a function of
behavior during baseline and the test period. Separate models
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FIGURE 3 | Loading plot from PCA of the pre-test data. Red is HR, blue
is RMSSD, black is HF, green is LF, and brown is used for LF/HF.
were created for HR and each of the individual HRV measures. In
Figure 4A, a plot of modeled recovery versus actual recovery for
HR is shown. Again, blue color is used to denote participants using
anti-depressants. The blue line represents perfect match between
modeled and actual response. Figure 4A shows a good correspon-
dence between measured and estimated HR for the whole group.
The HR behavior during recovery is possible to estimate for all test
participants, regardless of medication use.
This situation changes when looking at some of the HRV mea-
sures. Figure 4B illustrates the situation for RMSSD. For several
participants the model performance is poor. For five of the partic-
ipants (to the right), the actual RMSSD is far higher than expected
based on the model. There is also one participant (to the left)
with a measured RMSSD far lower than expected according to the
model. This interesting result shows that this group of patients,
all using anti-depressants, undergoes a different recovery phase
with regards to RMSSD, compared to the other patients. A simi-
lar behavior is experienced when studying LF, but not for HF, or
LF/HF.
THE CHANGE DATA
The most important data table investigated in this work was cre-
ated by subtracting the pre-test data from the post-test data. This
was done to focus on each participant’s change in HR and HRV
during the intervention. The score plot from PCA on this data set
(not shown), shows little sign of discrimination between the fish
and control group. A t-test on the scores confirms this (p = 0.0794,
Cohen’s d = 0.60).
However, clear separation between the fish and control group
can be achieved by controlling for medication. In Figure 5, two
score plots from PCA on a subset of participants free from heart
medication and anti-depressants are shown. Again, blue represents
intervention and red control. Figure 5A shows the results from a
PCA on this subset of participants. The ellipses in the plot are
Hotelling’s T2 limits (Jackson, 1991), which can be regarded as
a multivariate generalization of a t-test. An outlier is present in
the upper right quadrant of the plot. Removal of this outlier and
recalculation of the model yields the score plot in Figure 5B. Sepa-
ration is clearly visible, and a t-test on the mean value of the scores
of the first principal component (p = 0.00029, Cohen’s d = 2.72)
show that the two groups are different, and that the fish group has
undergone a change in HR and HRV different to the intervention
group.
A closer look at the status of subjects in the fish group is pre-
sented in Figure 6. This analysis was performed on the patients
whose medication was constant throughout the intervention. Red
is used to indicate the participants on constant medication, while
blue is used for the ones who did not receive any medication. With
the small sample size here, one should be careful with drawing
strong conclusions. However, separation of the groups is evident
from the score plot, as the patients not using medication is posi-
tioned more in the lower right part of the plot. This indicates a
difference in response to the intervention. Still, the small sample
size makes this observation less certain than the others presented
in this work. We have therefore not carried out any additional
statistical tests, but the plot generates the interesting hypothesis
that the participants on medication respond differently to the fish
diet.
The loading plot in Figure 7 illuminates why there is a sepa-
ration. The same color coding is used in this loading plot as in
Figure 3. HR variables are plotted in red, and blue has been used
for the RMSSD variables. The HF variables are in black, and green
has been used for LF. The LF/HF ratio is plotted in brown.
In the upper left region we find some of the LF, HF, and RMSSD
measures, whereas larger change in HR and LF/HF measures seem
to be associated with the participants not on medication.
DISCUSSION
The use of latent variables as a data analytical tool is probably new
to many readers. We do not suggest that these methods should
replace traditional statistical tests, but rather complement them.
Latent variables, in conjunction with statistical tests, showed a
successful randomization procedure, as seen in Figure 1. A pri-
ori knowledge of group membership can still be used effectively
by color coding the participants and variables accordingly to high-
light the information contained in the variance pattern of the data.
A PCA on the change data was initially unable to separate the fish
group from the control group (p = 0.0794, Cohen’s d = 0.60).
This is due to the criterion used to calculate the principal com-
ponents. The maximum variance criterion forces the principal
components to pick up the major variation sources, at the expense
of leaving minor, systematic changes unaccounted for. The effect
of medication was strong enough to hide the effect of the inter-
vention. Only by controlling for medicinal use a separation of
the two groups became visible in the score plots (p = 0.00029,
Cohen’s d = 2.72). Although there of course are huge individ-
ual HR and HRV variations due to other external factors, the
intervention group in general scores higher on the first principal
component. This demonstrates that whether or not a participant is
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FIGURE 4 | Plots of estimated recovery versus measured recovery. Blue – uses heart medication and/or anti-depressants. Red – does not use drugs.
(A) Recovery HR. (B) Recovery RMSSD.
on the fish diet is a major source of variation in the data. A similar
plot (not shown here) appears if one investigates only the subset
of participants, whose medication remained constant throughout
the intervention period, again indicating that the introduction of
fatty fish to the diet is a major source of variation once medication
is controlled for.
The use of quantitative regression modeling using latent vari-
ables has been shown for parts of the recovery data. The poor
performance of the model for RMSSD prediction for some of
the participants indicates that the recovery phase is different for
some of the participants on heavy medications. For the majority
of participants the model performance is good, so an interest-
ing question is to ask why the model fails for some participants.
A closer look at the medical records reveals that the partici-
pants in question are using a variety of heart medications and
anti-depressants; up to eight different drugs at the same time.
Thus, participants with a higher level of medication respond
differently during the recovery phase to the normal population.
Five of the six participants for which the prediction fails were
using statins, a cholesterol lowering drug which previously has
been shown to improve HRV (Riahi et al., 2002). Four partici-
pants were using fibrates, another cholesterol lowering drug which
has been reported to improve HRV (Melenovsky et al., 2003).
There seems to be little consensus in the literature as to what the
effects of SSRIs are on HRV (van Zyl et al., 2008; Kemp et al.,
2010; Licht et al., 2010). However, a recent large independent
cohort study showed that different antidepressants (e.g., tricyclic
antidepressant, SSRI) were related to lower HRV (Kemp et al.,
2014). The fact that the present recovery prediction model fails
for the HRV data for the participants on heavy medication, again
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FIGURE 5 | Score plot of the first two principal components of the
change data for the participants using neither heart medication nor
anti-depressants. Blue color is used for the fish group, and red for the
control group. (A) Outlier included. (B) Outlier excluded.
demonstrates the strong masking effect medication has on the
HRV.
The participants in this study were adult male forensic inpa-
tients. This is a group for which cognitive and executive functions
deficits have been demonstrated before (Galski et al., 1990). Thus,
based on the very high RMSSD during recovery in these partici-
pants on a mix of medication, one can speculate whether the level
of HRV during recovery may add some information about the
physiological effort invested in the task before the recovery. The
FIGURE 6 | Score plot of the first two principal components of the
change data for the participants in the fish group having either a
constant drug regime (blue) or receiving no medication (red).
FIGURE 7 | Loading plot of the change data using only the participants
in the fish group having a constant drug regime or receiving no
medication. Red: HR. Blue: RMSSD. Green: LF. Black: HF. Brown: LF/HF.
results fit a previously observed pattern, where increased HRV was
observed after exposure to a similar experimental mild-stress pro-
cedure (Hansen et al., 2003). Another study (Hansen and Johnsen,
2013) investigating the relationship between levels of neuroticism
and performance on non-executive functioning tasks (tasks based
on processes driven automatically), in both non-threatening and
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threatening situations, showed that participants with high neuroti-
cism exposed to a threat had a significant increase in HRV from
the task to recovery. This effect was absent when high neuroticism
participants were not exposed to threats. For low neuroticism par-
ticipants, this effect was absent regardless of threat level. In this
latter study it was speculated whether the absence of threat in
the recovery period caused the significant increase in HRV from
test to recovery, since subjects with high neuroticism usually are
characterized by low HRV. However, more research is needed to
conclude whether information from the recovery measure can add
something significant concerning mental and physical health.
Recently it was reported a strong relationship between tricyclic
antidepressant and coronary heart disease (Kemp et al., 2015).
Thus, as persons on heart medication and anti-depressants on
average can be regarded as having poorer health (and thus lower
life expectancy) than the general population, it is of interest to
look deeper into the role of a fish diet for this group. The score
and loading plots in Figures 6 and 7 generate the hypothesis that
the participants using heart medication and/or anti-depressants
throughout the fish intervention period experienced a larger
reduction in LF than the ones not using drugs. Thus, consider-
ing the debate about the autonomic origins of LF power (Thayer
et al., 2010; Xhyheri et al., 2012), the fact that 2 min data epochs
provide better estimates of LF (Thayer et al., 2010), and the present
findings, one could speculate whether the LF represents the sym-
pathetic activity, and that intake of fatty fish may be even more
beneficial for the participants on heart medication. However, there
is empirical evidence that LF power correlate highly with HF power
(Thayer and Lane, 2007). Because of this and the small sample size,
further investigation is necessary.
As with many diet intervention studies, the number of partici-
pants in this study is low. This becomes even more evident if trying
to control for the different types of medication in use. The number
of participants is not large enough to warrant a more thorough
analysis of the effects of the different medicines. One may also
speculate as to whether the effect of the medicines may really be
due to the underlying pathology, and not the medication. There is
a debate concerning this relationship and a recent study focusing
on depression demonstrated that reduction in HRV was related to
pathophysiological mechanisms rather than the effect of antide-
pressant (SSRI; see Brunoni et al., 2013). In the present study, all
participants diagnosed with CVD or depression was on medica-
tion. To discern between medication and pathology is therefore
not possible using this data set. Still, there are numerous reports
in the literature about the effects of various medications on HR
and HRV, and the effect we observe in our study thus seems rea-
sonable. The consistency in which the participants group when
controlling for medication gives credence to the findings presented
here. The focus on the change data and the subsequent explorative
multivariate analysis is not meant to replace traditional statistics.
We have also employed t-tests on the latent variables to indicate
whether the observed groupings are reasonable. Used in this way,
this approach represents a valuable addition to the data analytical
tools normally employed.
The original motivation behind this intervention experiment
was to look at the effect of the nutrition on mental health (e.g.,
Hansen et al., 2014a,b). The physical health benefits of introducing
fatty fish to our diet has been amply demonstrated in earlier pub-
lications. Van Horn et al. (2008) present a thorough review of
this dietary aspect with regards to CVDs. For institutions having
a clientele with a lower than average life expectancy, this effect
should be factored in when designing health improvement plans.
The question that remains to be answered is whether increased
fatty fish consumption can enhance the effect of traditional med-
ical treatment such as antidepressants and heart medication and
further increase the life expectancy. It has been reported that while
anti-depressants reduce the symptoms of depression, they may
leave the HRV at sub-optimal levels. As HRV is a strong predic-
tor of cardiac status, this indicates that persons suffering from
depression are vulnerable to CVDs. Thus, based on the present
data exploration it can be hypothesized that the beneficial effects
of an increased fatty fish intake are even larger for this group.
More knowledge about this will have important implications with
regards to the development of health improvement interventions
in psychiatric institutions.
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